Blog

GENETIC AND EPIGENTIC CHANGES IN ACUTE MYELOID LEUKEMIA

ATM INHIBITOR SENSITIZES GLIOBLASTOMA TO IONIZING RADIATION THERAPY

ACTIVATED MAPK PATHWAY LIMITS EFFICACY OF ROMIDEPSIN

The Hippo-YAP Pathway: New Connection between Cancer and Stem Cells.

Receptor Tyrosine Kinase “Hijacking” in Glioblastoma

DELAYING DRUG RESISTANCE AND PROLONGING SURVIVAL IN MELANOMA

HISTONE METHYLITRANSFERASE EZH2 IN CANCER

RESISTANCE TO B-RAF INHIBITORS IN MELANOMA

NRAS MUTATION IN MELANOMA